Reduction in the risk of major adverse cardiovascular events with the BET protein inhibitor apabetalone in patients with recent acute coronary syndrome, type 2 diabetes, and moderate to high likelihood of non-alcoholic fatty liver disease
-
Published:2022-09
Issue:
Volume:11
Page:100372
-
ISSN:2666-6677
-
Container-title:American Journal of Preventive Cardiology
-
language:en
-
Short-container-title:American Journal of Preventive Cardiology
Author:
Toth Peter P.ORCID,
Schwartz Gregory G.,
Nicholls Stephen J.,
Khan Aziz,
Szarek Michael,
Ginsberg Henry N.,
Johansson Jan O.,
Kalantar-Zadeh Kamyar,
Kulikowski Ewelina,
Lebioda Ken,
Wong Norman C.W.,
Sweeney Michael,
Ray Kausik K.
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献